Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 USD | -0.37% | -7.53% | +4.25% |
2023 | Protect Pharmaceutical Corporation announces an Equity Buyback for $10 million worth of its shares. | CI |
2023 | Protect Pharmaceutical Corporation authorizes a Buyback Plan. | CI |
Sales 2016 | - | Sales 2017 | - | Capitalization | 16.48M 1.3B |
---|---|---|---|---|---|
Net income 2016 | - 0 | Net income 2017 | - 0 | EV / Sales 2016 | - |
Net cash position 2016 * | - 0 | Net Debt 2017 | 101K 7.95M | EV / Sales 2017 | - |
P/E ratio 2016 |
-26.6
x | P/E ratio 2017 |
-7.25
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 1.92% |
1 day | -0.37% | ||
1 week | -7.53% | ||
1 month | +2.27% | ||
3 months | +8.00% | ||
6 months | +285.77% | ||
Current year | +4.25% |
Managers | Title | Age | Since |
---|---|---|---|
Yildiz Ali
CEO | Chief Executive Officer | - | - |
John Brannelly
LAW | General Counsel | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yildiz Ali
CEO | Chief Executive Officer | - | - |
Date | Price | Change | Volume |
---|---|---|---|
17/05/24 | 2.7 | -0.37% | 10,164 |
16/05/24 | 2.71 | +1.31% | 5,900 |
15/05/24 | 2.675 | -0.93% | 3,015 |
14/05/24 | 2.7 | -6.90% | 23,141 |
13/05/24 | 2.9 | -0.68% | 5,710 |
Delayed Quote OTC Markets, May 17, 2024 at 08:56 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+4.25% | 155M | |
-14.49% | 32.3B | |
-10.75% | 32.12B | |
-1.52% | 6.34B | |
-0.10% | 5.3B | |
-6.40% | 4.23B | |
+4.62% | 4.14B | |
0.00% | 3.86B | |
+9.31% | 3.84B | |
+72.76% | 2.64B |
- Stock Market
- Equities
- PRTT Stock